Neuromuscular dysfunction in the cancer patient: Evaluation and treatment

2018 ◽  
Vol 58 (3) ◽  
pp. 335-343 ◽  
Author(s):  
Jennifer A. Baima ◽  
Julie K. Silver ◽  
Mathew Most
Keyword(s):  
Cancer Patient ◽  
Patient Evaluation ◽  
Neuromuscular Dysfunction

Esophageal cancer: patient evaluation and pre-treatment staging

2001 ◽  
Vol 10 (3) ◽  
pp. 103-111 ◽  
Author(s):  
H.J. Stein ◽  
B.L.D.M. Brücher ◽  
A. Sendler ◽  
J.R. Siewert
Keyword(s):  
Esophageal Cancer ◽  
Cancer Patient ◽  
Esophageal Cancer Patient ◽  
Patient Evaluation ◽  
Pre Treatment

1565: Semen Cryopreservation in Adolescent Cancer Patient

2004 ◽  
Vol 171 (4S) ◽  
pp. 413-413
Author(s):  
Deborah M. Spaine ◽  
Renata Fraietta ◽  
Agnaldo P. Cedenho ◽  
Miguel Srougi
Keyword(s):  
Cancer Patient ◽  
Semen Cryopreservation ◽  
Adolescent Cancer

Turnover and Distribution of 131Iodine-Labelled Human Fibrinogen

1964 ◽  
Vol 11 (02) ◽  
pp. 404-422 ◽  
Author(s):  
Annemarie Amris ◽  
C. J Amris
Keyword(s):  
Body Weight ◽  
Cancer Patient ◽  
Distribution Ratio ◽  
Half Life ◽  
Fibrinolytic Activity ◽  
The Other ◽  
Turnover Rates ◽  
Human Fibrinogen ◽  
Coagulation Defects ◽  
Fractional Turnover

Summary14 patients (5 diabetics with arteriosclerotic complications, 4 patients with thrombo-embolic disease, 4 with cirrhosis, coagulation defects and increased fibrinolytic activity, and 1 cancer patient) and 3 control patients were subjected to turnover studies with 13iodine labelled human fibrinogen.Half-life times in the control patients were found to be 4 days, the fractional turnover rates 19–23 per cent, of intravascular fibrinogen per day, and the absolute turnover 0.02 to 0.06 gm per day per kg. body weight. The other patient’s half-life times and turnover rates varied considerably from 0.9–5.5 days, 13–160 per cent, per day of intravascular fibrinogen and 0.02–0.4 gm per day per kg. body weight respectively.As fibrinogen unlike other proteins subjected to turnover studies, is converted to fibrin, it is not possible to measure the true intra-extravascular distribution ratio of fibrinogen. But intravascular fibrinogen could be approximated to constitute 68–99 per cent, of the total fibrinogen. There is justification in believing that fibrinogen is degradated through a continuous coagulation in equilibrium with fibrinolysis, and that the organism contains a greater mass of fibrin, the “fibrin pool”. Considerations of the turnover mechanism can however only be hypothetical.

Percutaneous Pediculoplasty and Balloon Kyphoplasty in a Vertebral Metastatic Cancer Patient - A case report -

2007 ◽  
Vol 20 (2) ◽  
pp. 213 ◽  
Author(s):  
Ji Yon Jo ◽  
Jeong Hoon Suh ◽  
Hwa Yong Shin ◽  
Yong Min Choi ◽  
Moon Sun Bang ◽  
...  
Keyword(s):  
Case Report ◽  
Cancer Patient ◽  
Metastatic Cancer ◽  
Balloon Kyphoplasty
Sign in / Sign up

Export Citation Format

Share Document